Lord Abbett Health Care Fund Class R5 (LHCTX)

Fund Assets	3.27M
Expense Ratio	0.78%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	0.11
Dividend Yield	0.59%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Nov 26, 2024

Previous Close	18.49
YTD Return	-4.19%
1-Year Return	-5.00%
5-Year Return	27.68%
52-Week Low	16.71
52-Week High	21.07
Beta (5Y)	n/a
Holdings	58
Inception Date	Jul 31, 2019

About LHCTX

The Fund's investment strategy focuses on Health/Biotech with 0.78% total expense ratio. Lord Abbett Securities Trust: Lord Abbett Health Care Fund; Class R5 Shares seeks long-term capital appreciation. Under normal market conditions, LHCTX will invest at least 80% of its assets in equity and equity-related securities of health care-related companies. LHCTX may invest in the securities of issuers of different countries throughout the world, including the United States.

• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: LHCTX
• Share Class: Class R5
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCTX had a total return of -5.00% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.21%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCOX	Class F3	0.68%
LHCVX	Class R6	0.68%
LHCFX	Class F	0.78%
LHCIX	Class I	0.78%

Top 10 Holdings

44.38% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	11.69%
Boston Scientific Corporation	BSX	4.91%
Intuitive Surgical, Inc.	ISRG	4.88%
Stryker Corporation	SYK	3.68%
Gilead Sciences, Inc.	GILD	3.67%
argenx SE	ARGX	3.43%
Natera, Inc.	NTRA	3.20%
Tarsus Pharmaceuticals, Inc.	TARS	3.19%
Abbott Laboratories	ABT	2.86%
AstraZeneca PLC	AZN	2.84%

Dividend History

Ex-Dividend	Amount	Pay Date
Nov 26, 2024	$0.1101	Nov 26, 2024
Nov 22, 2022	$0.0233	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3182	Nov 24, 2020
Nov 21, 2019	$0.0069	Nov 21, 2019